SCHEMBL2849100

SCHEMBL2849100

Cc1ccc(O)cc1-c1cc(Cl)nc(N)n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGPAT2 O15120 8/20 0.64
HSP90AA1 P07900 9/20 0.51
HSP90AB1 P08238 9/20 0.51
KDM4E B2RXH2 1/20 0.46
NPC1 O15118 1/20 0.42
SRC P12931 1/20 0.42
CDC7 O00311 1/20 0.41
DAPK3 O43293 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41
PAK4 O96013 1/20 0.41
PIM1 P11309 1/20 0.41
PRKACA P17612 1/20 0.41
GRK5 P34947 1/20 0.41
MAP2K2 P36507 1/20 0.41
MAPK8 P45983 1/20 0.41
CSNK1A1 P48729 1/20 0.41
CDK8 P49336 1/20 0.41
CLK2 P49760 1/20 0.41
GSK3A P49840 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4286576 0.84 AGPAT2 (0.64) AGPAT2HSP90AA1HSP90AB1KDM4E
SCHEMBL4282163 0.84 HSP90AA1 (0.54) AGPAT2HSP90AA1HSP90AB1KDM4ECDC7
SCHEMBL4282884 0.84 AGPAT2 (0.67) AGPAT2HSP90AA1HSP90AB1KDM4E
SCHEMBL4289224 0.81 AGPAT2 (0.64) AGPAT2HSP90AA1HSP90AB1KDM4E
SCHEMBL3944332 0.81 HSP90AA1 (0.71) AGPAT2HSP90AA1HSP90AB1KDM4ECDC7
SCHEMBL4288458 0.79 HSP90AA1 (0.76) AGPAT2HSP90AA1HSP90AB1KDM4ENPC1
SCHEMBL29571104 0.79 HSP90AA1 (0.70) AGPAT2HSP90AA1HSP90AB1KDM4ECDC7
SCHEMBL3952089 0.79 HSP90AA1 (0.70) AGPAT2HSP90AA1HSP90AB1KDM4ECDC7
SCHEMBL2850401 0.74 BACE1 (0.52) HSP90AA1HSP90AB1KDM4E
SCHEMBL24298190 0.73 HSP90AA1 (0.55) AGPAT2HSP90AA1HSP90AB1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362236-B2 Macrocyclic compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2013-01-29 US disclosed
US-8362236-B2 Macrocyclic compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2013-01-29 US disclosed
US-8362236-B2 Macrocyclic compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2013-01-29 US disclosed
EP-2119718-B1 MACROCYCLIC COMPOUND CHUGAI PHARMACEUTICAL CO LTD (JP) 2012-04-11 EP disclosed
EP-2119718-B1 MACROCYCLIC COMPOUND CHUGAI PHARMACEUTICAL CO LTD (JP) 2012-04-11 EP disclosed
CN-101675059-A Macrocyclic compounds CHUGAI PHARMACEUTICAL CO LTD 2010-03-17 CN disclosed
US-20100056510-A1 Macrocyclic Compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2010-03-04 US disclosed
US-20100056510-A1 Macrocyclic Compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2010-03-04 US disclosed
US-20100056510-A1 Macrocyclic Compound CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2010-03-04 US disclosed
EP-2119718-A1 MACROCYCLIC COMPOUND Chugai Seiyaku Kabushiki Kaisha (JP) 2009-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056510-A1 Macrocyclic Compound HSP90AB1, HSP90B1, HSP90AA1 AGPAT2 3274/4885HSP90AA1 3/4885HSP90AB1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.